Home » Drug Information » Recently Approved Drugs » 1998
Medical Areas: Immunology/Infectious Diseases | Pulmonary/Respiratory Diseases
Drug Information
The following information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: Morton Grove Pharmaceuticals
Approval Status: Approved March 1998
Treatment Area: allergic rhinitis
Clemastine Fumarate Syrup 0.5 mg/5 ml, a generic version of
Novartis' Tavist Syrup, has been approved for the treatment of
allergic rhinitis.